24/05/2016

WESTFORD, Mass. PRNewswire | Shipments of New 1064 nm Wavelength to Begin in the Second Half of 2016. Broadening its product platform for tattoo removal and skin revitalization, Cynosure, Inc. CYNO, -1.81% today announced that it has received U.S. Food and Drug Administration 510(k) clearance to market a new Laser Delivery System for PicoSure®, the world’s first aesthetic picosecond laser. Together with the FDA cleared 532 nm and 755 nm wavelengths, Cynosure’s new 1064 nm Laser Delivery System improves the multi-wavelength laser technology for removing the full color spectrum of tattoo inks in fewer treatments.

zum Artikel